Cancer Therapy:

MEDICAL REPORT

Dr X was diagnosed on the 7th of July 2006 with a high grade non-Hodgkin’s lymphoma.  The tumour was retro-peritoneal and measured 19 x 16 x 13 cm.  There was also a degree of bone marrow involvement.

  The following treatment was indicated:

  1.                  Intensive 3 weekly chemotherapy treatment involving mapthera (immunotherapy) and CHOP.

  2.                  Daily 1 hour treatment with Panag machine.

  3.                  High dosages of vitamins and antioxidants supplements with glyco nutrients.  

After 9 weeks of treatment the tumour has decreased by 70% in size.
  
It was then decided to continue with the same therapy.

After 20 weeks of treatment the bone marrow involvement was completely clear and the tumour has shrunk to 3% of the original size.  A further two chemotherapy sessions will be given and then all the sessions will stop.  

Usually persons on chemotherapy experience bad side effects such as:  painful mouth ulcers, diarrhoea, changes in white blood counts and platelet counts which makes them more susceptible to severe infection for example pneumonia.  

Dr X experienced none of the above symptoms.

This might be attributed to the regular use of the Panag machine.

_________________________________________________________________

 The Pain Management Therapy:

To whom it may concern: 

I commenced using Panag treatment with patients for many different complaints such as nerveroot compression, musculoskeletal pain, inflammation and neuropathic pain and many ofmy patients have improved or resolved their problems. I intend to document these patients withtheir progress for a more comprehensive analysis of results. 

I have now commenced with treatment of cancer patients to improve their immune system,relieve pain emanating from an organ that is compressing nerves such as liver, kidney andabdomen and improve energy and appetite. 

My first patient, female (AB) was referred on 15/05/07 by her oncologist and psychologist. Sheis 33 years of age, diagnosed with breast cancer – stage 4 with spread into liver and lungsthree years previously. She was in remission for 2 years and then developed lymphoma withnodes in the left mediastinum and stomach region. She received 3 courses of chemotherapyand 10 sessions of radiation. 

She now complains of back pain from mid-thoracic to the level of lumbar vertebrae 2, pain inthe abdomen especially on the right (liver region), nausea, vomiting of bile, inability to maintainfood intake and listlessness. She is unable to sleep due to the pain.

I commenced Panag treatment with vaginal probe, electrodes on the mid-back and abdomenand electrodes over the sternum in the region of the tumours for 1 hour. Three treatments havebeen given to this date and the nausea, listlessness and most of the abdominal pain hasresolved. The patient has enjoyed eating and has not vomited. She still had back pain beforeher third treatment today which resolved by the end of the treatment. There was a gap of 4days between treatment 2 and 3. 

Treatment will be continued this week and will prevail during a new chemotherapy programmewhich commences next week. 

References available on request.

_________________________________________________________________

Experiences with the Panag Multitherapy device between May 2001 – December 2008.

GP REPORT

Doctor’s reference available on request.

The device was used in the surgery for various conditions (see accompanying pie chart). As can be seen the majority of patients treated were HIV/AIDS patients.

 

Group A:

HIV/AIDS Autoimmune diseases like arthritis, asthma, dermatitis. Chronic fatigue syndrome Diabetes mellitus type 2 

 
Group B: Viral and bacterial infections 

1.     Pulmonary and abdominal TB

2.     Pneumonia

3.     Herpes infections

4.     Candidacies: Oral, gastrointestinal, vaginal.

 

Group C: Various cancers.

Kaposi sarcoma Ca liver Ca cervix Ca prostate

 

Group D: Other conditions

Abnormal uterus bleeding Endometriosis Cerebrovascular Accidents Other types of arthritis osteoarthritis gouty arthritis.

 

Results: 

All patients responded positively and immediately. The longer the treatment taken the better the results. Unfortunately most of the patients did not take the treatment regularly and for a long enough time.
 

Conclusion A:

The device seems to work mainly on the immune system as seen clinically during treatments. Lymphocyte (CD3, CD4, CD8) and viral load counts show dramatic improvements as corroborated by figures in the protocol.

Referring to tests that were recorded during treatment of endometriosis, dramatic change of IL 12 levels is further evidence that the device affects the immune system directly.

 

Conclusion B:

Its beneficial effects on pain and mobility, point to the fact that it works through prostaglandins and various other endomorphins too. 
 

Conclusion C:

The device’s fast and consistent action can be attributed to the fact that it is introduced directly into the body through the rectum, vagina and mouth. This is unique as all other devices are always applied externally.

 

Conclusion D: 

Over the years the device has been found to be safe with no side effects. It has been used even in children without any adverse observations. 

In my experience this is the only device that can be used at the bedside of a sick patient effectively. It has the advantages of being portable, painless to use and can treat a lot of conditions (immune system related) simultaneously.  

We all know that a sick person irrespective of anatomical site is always deficient in physiological energy (which is always electrical energy). When you use the Panag you give the body a lot of electrical energy. The device is built in such a way that the body can readily transform this energy into physiological electrical energy. This surplus energy is distributed throughout the body and enables it to carry its normal functions.